Clinical Trial Update: DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study called DUMAS evaluating neo-adjuvant immunotherapy for Pancoast tumors associated with non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pancoast Tumor

Snippet

Sponsor: Fundación GECP | Conditions: NSCLC, Pancoast Tumor | Phase 2 | Status: RECRUITING